Obesity: pathophysiology and clinical management.
paper
Cited
Public
Unavailable
- Authors
- Gurevich-Panigrahi, Tatiana; Panigrahi, Soumya; Wiechec, Emilia; Los, Marek
- Year
- 2009
- Journal
- Current medicinal chemistry
- PMID
- 19199918
- DOI
- 10.2174/092986709787315568
Obesity is an increasingly serious socioeconomic and clinical problem. Between (1/4)-(1/3) of population in the developed countries can be classified as obese. Four major etiological factors for development of obesity are genetic determinants, environmental factors, food intake and exercise. Obesity increases the risk of the development of various pathologic conditions including: insulin-resistant diabetes mellitus, cardiovascular disease, non-alcoholic fatty liver disease, endocrine problems, and certain forms of cancer. Thus, obesity is a negative determinant for longevity. In this review we provide broad overview of pathophysiology of obesity. We also discuss various available, and experimental therapeutic methods. We highlight functions of adipocytes including fat storing capacity and secretory activity resulting in numerous endocrine effects like leptin, IL-6, adiponectin, and resistin. The anti-obesity drugs are classified according to their primary action on energy balance. Major classes of these drugs are: appetite suppressants, inhibitors of fat absorption (i.e. orlistat), stimulators of thermogenesis and stimulators of fat mobilization. The appetite suppressants are further divided into noradrenergic agents, (i.e. phentermine, phendimetrazine, benzphetamine, diethylpropion), serotoninergic agents (i.e. dexfenfluramine), and mixed noradrenergic-serotoninergic agents (i.e. sibutramine). Thus, we highlight recent advances in the understanding of the central neural control of energy balance, current treatment strategies for obesity and the most promising targets for the development of novel anti-obesity drugs.
No figures extracted from this document.
No chunks โ full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | 2019 | 29568101 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Design, synthesis, and biological evaluation of novel quinoline carboxylic acid based styryl/alkyne hybrid molecule as a potent anti-adipogenic and antidyslipidemic agent via activation of Wnt/ฮฒ-catenin pathway. | Singh R et al. | โ | 2025 | โ |
| Effects of oral supplementation of probiotics on body weight and visceral fat in obese patients: a meta-analysis and systematic review. | Guo M et al. | โ | 2025 | โ |
| Antiobesity Drug Discovery Research: <i>In vitro</i> Models for Shortening the Drug Discovery Pipeline. | Radheshyam et al. | โ | 2024 | โ |
| Pharmacological Activity of Cha-Miang (<i>Camellia sinensis</i> var. <i>assamica</i>) in High Fat Diet-Induced Insulin-Resistant Rats. | Laoung-On J et al. | โ | 2024 | โ |
| Anti-Obesity Actions of Two Separated Aqueous Extracts From Arbutus (<i>Arbutus unedo</i>) and Hawthorn (<i>Crataegus monogyna</i>) Fruits Against High-Fat Diet in Rats via Potent Antioxidant Target. | Wahabi S et al. | โ | 2023 | โ |
| Comparing and contrasting different herbal products intended for the management of obesity approved in the Palestinian markets. | Eid AM et al. | โ | 2023 | โ |
| Pharmaceutical Therapies for the Treatment of Obesity: A Network Meta-analysis. | Morsali M et al. | โ | 2023 | โ |
| The combined effect of metformin and mirabegron on diet-induced obesity. | Zhao XY et al. | โ | 2023 | โ |
| The Interaction between Mushroom Polysaccharides and Gut Microbiota and Their Effect on Human Health: A Review. | Zhao J et al. | โ | 2023 | โ |
| Adaptive thermogenesis after moderate weight loss: magnitude and methodological issues. | Nunes CL et al. | โ | 2022 | โ |
| Anti-Obesity Effects of <i>Ecklonia cava</i> Extract in High-Fat Diet-Induced Obese Rats. | Abbas MA et al. | โ | 2022 | โ |
| Changes in food reward and intuitive eating after weight loss and maintenance in former athletes with overweight or obesity. | Nunes CL et al. | โ | 2022 | โ |
| Does morbid obesity influence perioperative outcomes after video-assisted thoracic surgery (VATS) lobectomy for non-small cell lung cancer? Analysis of the Italian VATS group registry. | Guerrera F et al. | โ | 2022 | โ |
| In vivo morphological study of obese development in mice model guided by swept-source optical coherence tomography (SSOCT). | Indoliya A et al. | โ | 2022 | โ |
| Adenovirus-36 as one of the causes of obesity: the review of the pathophysiology. | Cancelier ACL et al. | โ | 2021 | โ |
| Association between Breakfast Skipping and Body Weight-A Systematic Review and Meta-Analysis of Observational Longitudinal Studies. | Wicherski J et al. | โ | 2021 | โ |
| Controlled Transdermal Iontophoresis of Insulin from Water-Soluble Polypyrrole Nanoparticles: An In Vitro Study. | Tari K et al. | โ | 2021 | โ |
| <i>Scolymus hispanicus</i> (Golden Thistle) Ameliorates Hepatic Steatosis and Metabolic Syndrome by Reducing Lipid Accumulation, Oxidative Stress, and Inflammation in Rats under Hyperfatty Diet. | Berdja S et al. | โ | 2021 | โ |
| The phosphatidylserine flippase ฮฒ-subunit Tmem30a is essential for normal insulin maturation and secretion. | Yang Y et al. | โ | 2021 | โ |
| Anti-Obesity and Antidiabetic Effects of Nelumbinis Semen Powder in High-Fat Diet-Induced Obese C57BL/6 Mice. | Hwang SB et al. | โ | 2020 | โ |
| Champ4life Study Protocol: A One-Year Randomized Controlled Trial of a Lifestyle Intervention for Inactive Former Elite Athletes with Overweight/Obesity. | Silva AM et al. | โ | 2020 | โ |
| Chemistry, Analysis, Pharmacokinetics and Pharmacodynamics Aspects of Lorcaserin, a Selective Serotonin 5-HT2C Receptor Agonist: An Update. | Sharma S et al. | โ | 2020 | โ |
| Anti-obesity effects of dichloromethane leaf extract of <i>Gnidia glauca</i> in high fat diet-induced obese rats. | Arika WM et al. | โ | 2019 | โ |
| Characterizing Eckol as a Therapeutic Aid: A Systematic Review. | Manandhar B et al. | โ | 2019 | โ |
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | Wang K et al. | โ | 2019 | โ |
| Insights on modulators in perception of taste modalities: a review. | Deepankumar S et al. | โ | 2019 | โ |
| The effects of <i>Crataegus pinnatifida</i> (Chinese hawthorn) on metabolic syndrome: A review. | Dehghani S et al. | โ | 2019 | โ |
| Thiol/Disulphide Homeostasis, Ischemia Modified Albumin, and Ferroxidase as Oxidative Stress Markers in Women with Obesity with Insulin Resistance. | Ates E et al. | โ | 2019 | โ |
| Anti-obesity effects of pectinase and cellulase enzymeโtreated Eckloniaย cava extract in highโfat dietโfed C57BL/6N mice. | Kim IH et al. | โ | 2018 | โ |
| Grifola frondosa (Maitake) extract activates PPARฮด and improves glucose intolerance in high-fat diet-induced obese mice. | Aoki H et al. | โ | 2018 | โ |
| Pediatric obesity: Current concepts. | Greydanus DE et al. | โ | 2018 | โ |
| New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. | Mokarram P et al. | โ | 2017 | โ |
| AMPK/Mitochondria in Metabolic Diseases. | Bullon P et al. | โ | 2016 | โ |
| Changes in Bone Metabolism in Morbidly Obese Patients After Bariatric Surgery: A Meta-Analysis. | Liu C et al. | โ | 2016 | โ |
| ERK1/2 activation in human taste bud cells regulates fatty acid signaling and gustatory perception of fat in mice and humans. | Subramaniam S et al. | โ | 2016 | โ |
| FADD is a key regulator of lipid metabolism. | Zhuang H et al. | โ | 2016 | โ |
| Identification of 1H-indene-(1,3,5,6)-tetrol derivatives as potent pancreatic lipase inhibitors using molecular docking and molecular dynamics approach. | Kalathiya U et al. | โ | 2016 | โ |
| A Herbal Formula HT048, Citrus unshiu and Crataegus pinnatifida, Prevents Obesity by Inhibiting Adipogenesis and Lipogenesis in 3T3-L1 Preadipocytes and HFD-Induced Obese Rats. | Lee YH et al. | โ | 2015 | โ |
| Ginger extract prevents high-fat diet-induced obesity in mice via activation of the peroxisome proliferator-activated receptor ฮด pathway. | Misawa K et al. | โ | 2015 | โ |
| Pharmacological inhibition of PI3K reduces adiposity and metabolic syndrome in obese mice and rhesus monkeys. | Ortega-Molina A et al. | โ | 2015 | โ |
| PPARฮฑ-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation. | Gao Q et al. | โ | 2015 | โ |
| Pycnogenolยฎ in Metabolic Syndrome and Related Disorders. | Gulati OP | โ | 2015 | โ |
| Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. | Acosta A et al. | โ | 2015 | โ |
| Cell adhesion molecules and their relation to (cancer) cell stemness. | Farahani E et al. | โ | 2014 | โ |
| In case of obesity, longevity-related mechanisms lead to anti-inflammation. | Kaya MS et al. | โ | 2014 | โ |
| NAFLD leads to liver cancer: do we have sufficient evidence? | Duan XY et al. | โ | 2014 | โ |
| Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. | Chaabane W et al. | โ | 2013 | โ |
| Enzymatically synthesized glycogen reduces lipid accumulation in diet-induced obese rats. | Furuyashiki T et al. | โ | 2013 | โ |
| Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases. | Hashemi M et al. | โ | 2013 | โ |
| Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. | Coulon S et al. | โ | 2012 | โ |
| Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex. | Rezin GT et al. | โ | 2012 | โ |
| Polyphenol-Rich Fraction of Brown Alga Ecklonia cava Collected from Gijang, Korea, Reduces Obesity and Glucose Levels in High-Fat Diet-Induced Obese Mice. | Park EY et al. | โ | 2012 | โ |
| Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. | Park JB et al. | โ | 2012 | โ |
| Sustained activation of PPARฮฑ by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. | Huang J et al. | โ | 2012 | โ |
| Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. | Jadhav RD et al. | โ | 2012 | โ |
| Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension. | Bekki H et al. | โ | 2011 | โ |
| Synthesis and biological evaluation of new flavonoid fatty acid esters with anti-adipogenic and enhancing glucose consumption activities. | Zhao W et al. | โ | 2011 | โ |
| Estrogen receptor-{beta}-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. | Yepuru M et al. | โ | 2010 | โ |
| Gastrointestinal symptoms and diseases related to obesity: an overview. | Foxx-Orenstein AE | โ | 2010 | โ |
| Regulation of adipokine secretion by n-3 fatty acids. | Moreno-Aliaga MJ et al. | โ | 2010 | โ |
| Synthesis and biological evaluation of isoflavone fatty acid esters with potential weight loss and hypolipidemic activities. | Xiang H et al. | โ | 2010 | โ |
| Adipocytokines in sleep apnea syndrome. | Wysocka E et al. | โ | 2009 | โ |
| Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity. | Danilova OV et al. | โ | 2009 | โ |